Viridian Therapeutics, Inc.\DE (VRDN) Cash from Discontinued Operations (2013)
Viridian Therapeutics, Inc.\DE's (VRDN) quarterly Cash from Discontinued Operations came in at 50125.0 in Q4 2013, little changed quarter-over-quarter from 50000.0 in Q3 2013.
Viridian Therapeutics, Inc.\DE (VRDN) Cash from Discontinued Operations (2013) Analysis & Trends
Viridian Therapeutics, Inc.\DE's Cash from Discontinued Operations history runs 1 years deep, the most recent figure standing at 50125.0 for Q4 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Viridian Therapeutics, Inc.\DE | 631.55 Mn | 631.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | -50,125.00 |
| Dec 31, 2013 | -50,125.00 |
| Sep 30, 2013 | -50,000.00 |
| Sep 30, 2013 | -50,000.00 |